Safety and efficacy of lenalidomide in combination with rituximab in recurrent indolent non-follicular lymphoma: final results of a phase II study conducted by the Fondazione Italiana Linfomi

• Stefano Sacchi,
• Raffaella Marcheselli,
• Alessia Bari,
• Gabriele Buda,
• Anna Lia Molinari,
• Luca Baldini,
• Daniele Vallisa,
• Marina Cesaretti,
• Pellegrino Musto,
• Sonia Ronconi,
• Giorgina Specchia,
• Franco Silvestris,
• Luciano Guardigni,
• Angela Ferrari,
• Annalisa Chiapella,
• Angelo Michele Carella,
• Armando Santoro,
• Francesco Di Raimondo,
• Luigi Marcheselli,
• Samantha Pozzi

Affiliations

Stefano Sacchi

Department of Diagnostic, Clinical and Public Health Medicine University of Modena and Reggio Emilia, Rimini

Raffaella Marcheselli

Department of Diagnostic, Clinical and Public Health Medicine University of Modena and Reggio Emilia, Rimini

Alessia Bari

Department of Diagnostic, Clinical and Public Health Medicine University of Modena and Reggio Emilia, Rimini

Gabriele Buda

Division of Hematology, University of Pisa, Rimini

Anna Lia Molinari

Hematology Unit, Infermi Hospital, Rimini

Luca Baldini

Department of Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori and University of Milan, Piacenza

Daniele Vallisa

Hematology Unit, Guglielmo da Saliceto Hospital, Piacenza

Marina Cesaretti

Department of Diagnostic, Clinical and Public Health Medicine University of Modena and Reggio Emilia, Rimini

Pellegrino Musto

Hematology and SCT Unit, IRCCS-CROB, Centro di Riferimento Oncologico della Basilicata, Rionero in Vulture, Meldola

Sonia Ronconi

Hematology Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola

Giorgina Specchia

Unit of Hematology with Transplantation, Department of Emergency and Organ Transplantation, University of Bari, Reggio Emilia

Franco Silvestris

Department of Biomedical Sciences and Human Oncology, University of Bari “A. Moro”, Reggio Emilia

Luciano Guardigni

Division of Internal Medicine, Cesena Hospital, Hematology Unit, Azienda Ospedaliera Arcispedale Santa Maria Nuova, IRCCS, Reggio Emilia

Angela Ferrari

Annalisa Chiapella

Department of Hematology, Città della Salute e della Scienza Hospital and University of Torino, Genova

Angelo Michele Carella

Hematology Unit, San Martino Hospital, Genova

Armando Santoro

Department of Hematology & Oncology, Humanitas Cancer Center, Humanitas Clinical & Research, Rozzano

Francesco Di Raimondo

Division of Haematology, AOU “Policlinico-Vittorio Emanuele”, University of Catania, Italy

Luigi Marcheselli

Department of Diagnostic, Clinical and Public Health Medicine University of Modena and Reggio Emilia, Rimini

Samantha Pozzi

Department of Diagnostic, Clinical and Public Health Medicine University of Modena and Reggio Emilia, Rimini